Прозрачность – одна из главных потребностей фармрынка

The Healthcare Ministry published a list of risks for effective drug circulation oversight, signaling that the relationship between the regulator and the industry has reached a new level. The HM Ordnance No. 57 dd. February 13, 2024, clearly lists negative situations that companies have to prevent. When the government details the risks themselves and the oversight procedures, it is a good sign for the market pointing to the age of inspections that followed murky criteria is almost over.

When it comes to the distribution link, the pharma market itself remains the same in most areas: the top 3 in the bulk sales areas did not change in 2020-2023. However, the rapid rise of FC Grand Capital, followed by stable retention of its position has to be noted separately. In that period, the company managed to seize the 4th place by growing its sales 65%.

I believe that the gap between the top 4 and the rest will only keep growing. There is no reason to expect the competition to become less fierce in the nearest future, because the pharma market is still a low-margin one.

At the same time, transparency is still one of the market's more pressing issues and demands. Therefore, increasing the security amounts and making (once again) the entire 'pharmacy - distributor - manufacturer' chain more transparent is going to stabilize the industry, protect it from shocks and make those actors who work in good faith feel more secure.

When choosing a partner, we assess their reliability, stability and payment capacity. We are focused on improving existing services and providing the market with new ones. Those are our main competitive advantages.

Our goal is to engage as many domestic pharmacies of every format as we can. We value every reliable partner equally. There are enough small and medium pharmacies in our sales profile.

Online services are definitely also significant and carry great promise. We are developing them proactively. The market and societal trends point to the share of online orders growing, so we are going to keep improving that segment.

On top of logistics and online tools, we also take social responsibilities, running weekly drug deliveries to remote areas using road, air and rail transport.

Satisfying a client’s needs and extra tools are main things that help us not only contact potential pharmacy partners, but engage them in a rewarding way down the road.

Link: Transparency as a key demand for the pharma market / Expert Opinion